The simple moving average for the past 20 days is -1.23% for HIT’s stock, with a -1.23% simple moving average for the past 200 days.
Is It Worth Investing in Health In Tech Inc (NASDAQ: HIT) Right Now?
The price-to-earnings ratio for Health In Tech Inc (NASDAQ: HIT) is above average at 156.25x,
HIT currently public float of 0.04M.The average trading volume of HIT on January 03, 2025 was 344.81K shares.
HIT) stock’s latest price update
The stock price of Health In Tech Inc (NASDAQ: HIT) has surged by 0.57 when compared to previous closing price of 5.22, but the company has seen a -0.57% decline in its stock price over the last five trading sessions. prnewswire.com reported 2024-12-24 that STUART, Fla., Dec. 24, 2024 /PRNewswire/ — Health In Tech, an Insurtech platform company backed by third-party AI technology, today announced the closing of its initial public offering of 2,300,000 shares of its Class A common stock at a public offering price of $4.00 per share, for gross proceeds of $9,200,000, before deducting underwriting discounts, commissions, and estimated offering expenses.
HIT Trading at -1.23% from the 50-Day Moving Average
After a stumble in the market that brought HIT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.26% of loss for the given period.
During the last 5 trading sessions, HIT rose by +2.08%, in comparison to the 20-day moving average. In addition, Health In Tech Inc saw -1.96% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HIT
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.62.
Conclusion
In a nutshell, Health In Tech Inc (HIT) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
